NCT06703450
Guerbet Liver Fibrosis
Enrolling by Invitation
Not specifiedAges 18–89ObservationalIcahn School of Medicine at Mount SinaiInvestigator-initiated
~50 participants
Updated 2026-04-21 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Liver Stiffness by MR Elastography
Measured over during procedure (MRI)
Conditions
Where it's being run
1 sites across 1 statesNew York1
Study leadership
- Sara Lewis, MD · PRINCIPAL_INVESTIGATOR · Icahn School of Medicine at Mount Sinai
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients with suspected MASLD (F0-F4) with clinically indicated percutaneous or transjugular liver biopsy within 6 months of MRI (before or after MRI).
Both genders.
Age \> 18 years.
Any racial/ethnic background.
Exclusion
Previous history or current diagnosis of HCC or decompensation.
Contraindications for MRI, including
Medically unstable
Intracranial clips
Metal implants
Suspected or confirmed metal in eyes
Cardiac pacemaker, implanted defibrillator, other implanted electronic device
Pregnancy: Pregnancy tests will be offered to women of childbearing age at no cost
Severe claustrophobia
What this trial measures
- Liver Stiffness by MR Elastographyduring procedure (MRI)
Liver stiffness that is quantitively measured by MR Elastography and correlated with grade of tissue fibrosis from histopathology. Min and Max Scale: 0-20 kilopascals (continuous variable). Higher score indicates poorer health outcomes.